Hepatic Failure Clinical Trial
Official title:
Study of High - Flux Plasma Diafiltration Based on Plasma - Saved Mode in the Treatment of Patients With Hepatic Failure
At present, there is no comparative study between the simple plasma exchange and plasma diafiltration (PDF), and no further exploration of optimal plasma dose in PDF treatment. Therefore, this prospective randomized cohort study aims to compare the safety and effectiveness of the tree groups（simple plasma exchange group, conventional PDF treatment group, less plasma PDF treatment group）by collecting SOFA score, 3-month survival rate, MELD score, and the times of artificial liver treatment , blood cell variables, cytokines(e.g. TNFα ), pre- and post-treatment plasma ammonia levels. Thus, it is to provide a safer and more effective artificial liver treatment with less plasma dose.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02516319 -
Liver Function Assessment - Feasibility and Dosing Study
|
N/A | |
| Completed |
NCT04587622 -
Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment
|
Phase 1 | |
| Recruiting |
NCT05604469 -
The Role of Skin Microbiota in Hepatic or Renal Pruritus
|
||
| Completed |
NCT03576859 -
Pyrophosphate Homeostasis and Hepatic Expression of ABCC6.Pyro-TH
|
N/A | |
| Withdrawn |
NCT02552901 -
Cardiox Liver Function Test Pivotal Trial
|
Phase 3 | |
| Completed |
NCT03515980 -
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
|
Phase 1 | |
| Recruiting |
NCT06179368 -
Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
|
||
| Completed |
NCT00831532 -
Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function
|
Phase 1 | |
| Completed |
NCT01846455 -
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
|
Phase 4 |